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ABSTRACT
A developing oocyte is capable of synthesizing "non-self" proteins 
recognized as foreign by the maternal immune system. Since the oocyte 
may be perceived as foreign it must be protected from interaction with the 
immune system in order for it to mature to the point of ovulation. Oocytes 
that begin development but do not mature to the point of ovulation become 
atretic and are destroyed and phagocytized by the maternal system. This 
study proposes that the zona pellucida of the ovarian follicle is the barrier 
between the immune system and the oocyte. The suggestion is made that 
the oocyte may play a role in blocking the immune system during its 
maturation, and follicles in which the oocyte is incapable of providing for 
its own protection become atretic.
Indirect immunolabelling techniques employing both peroxidase and 
fluorochrome-conjugated antibodies were used to assess the presence of 
immunoglobulin G, female protein, and albumin in the ovary of the golden 
hamster Mesocricetus auratus. This experimental technique indicates that 
immunoglobulin G, female protein, and albumin are found localized in the 
zona pellucida and liquor folliculi of ovarian follicles.
Intravenous injection of fluorescein-conjugated hamster im­
munoglobulin G demonstrates the ability of the zona pellucida to limit 
access of serum immunoglobulin G to the oocyte. The labelled im­
munoglobulin G circulates rapidly through the animal and does not appear 
to be impeded in its access to the follicle. It accumulates rapidly in the
Xll
liquor folliculi and zona pellucida yet never appears within the perivitelline 
space.
The results of this study suggest that the zona pellucida is 
responsible for separating the developing oocyte from the maternal immune 
system, thus forming a "blood-oocyte" barrier to immunoglobulins. 
Further speculation is made that the oocyte plays a role in its own 
protection by production of factors capable of blocking complement 
fixation. If incapable of providing for its own protection, the oocyte is 
acted upon by the maternal immune system. The zona pellucida and liquor 
folliculi aid the immune system by providing an area for local storage of 
proteins necessary to accomplish complement fixation and subsequent 
follicular atresia.
xm
INTRODUCTION
The gonads of all animals are complex organs which are not only 
subjected to hormonal regulation, but are also involved in the process of 
reproduction by their production of gametes and hormones.
In the male, the testis is the site of production of spermatozoa. This 
process is termed spermatogenesis. Spermatogenesis is a complex process 
which can be subdivided into four separate stages. The first and second 
stages involve cell division. The first stage utilizes mitosis to maintain a 
population of undifferentiated stem cells called spermatogonia. This step is 
termed spermatocytogenesis. The next stage, called meiosis, involves the 
ultimate production of a haploid cell, called the spermatid. These cells 
subsequently differentiate into spermatozoa through spermiogenesis. 
Meiosis involves two successive nuclear divisions with one division of 
chromosomes. Spermatogenesis results in the formation of 8 haploid 
spermatozoa from one diploid cell, the type B spermatogonia. Briefly, the 
process of spermatogenesis is as follows: preleptotene primary 
spermatocytes undergo DNA synthesis and therefore contain 4n DNA, and 
2n chromosome number. These cells then enter the prophase of meiosis I. 
During this extended prophase there is pairing of homologous 
chromosomes, after which there is an interchange of chromatid segments 
between the homologous pairs. This interchange is termed crossing-over 
and ensures genetic diversity (Sadler, 1985; Dym, 1983). Meiosis I is also
1
2termed the reductional division since the resultant cells, the secondary 
spermatocytes, have 2n DNA and In chromosome number. 
Secondary spermatocytes then undergo meiosis II to form spermatids. 
Spermatids contain In DNA and In chromosome number, and are referred 
to as haploid cells.
A haploid cell is no longer recognized by the body as being "self", 
due to the synthesis of proteins that are encoded by DNA of chromosomes 
formed through crossing-over. Cell surface antigens specific to adluminal 
spermatocytes have been identified (Millette and Bellve, 1977; O'Rand and 
Romrell, 1977). The antigens appear during the pachytene stage of the 
first meiotic prophase, and are expressed by all germ cells at subsequent 
stages of division. This indicates that pachytene primary spermatocytes 
are capable of extensive gene transcription and translation (Millette and 
Bellve, 1977). If spermatids produce antigenic proteins the interaction 
between these proteins and circulating immunocytes may induce the 
formation of antibodies that could lead to autoimmune phenomena. A 
protective mechanism must exist which limits the interaction of the proteins 
of the germ cell coat and the blood circulatory system. The morphological 
basis of such a mechanism is found at the level of the Sertoli cell and is 
referred to as the blood-testis barrier. As the spermatocyte undergoes 
meiosis I it is isolated by adjacent Sertoli cells, which send out cellular 
processes beneath the spermatocyte and connect to each other through tight 
junctions (Dym, 1973). In fact, spermatocytes are protected by the blood- 
testis barrier before they become true haploid cells. This subdivides the 
seminiferous tubule epithelium into two compartments, the adluminal
3compartment which lies on the lumen side of the tight junctions, and the 
basal compartment which lies at the basal end of the Sertoli cell. Thus the 
basal compartment contains spermatogonia and preleptotene primary 
spermatocytes and the adluminal compartment contains the more advanced 
stages of germ cell differentiation (Dym, 1973). It is clear from the above 
that this barrier enables the Sertoli cells to maintain a microenvironment in 
the adluminal compartment which is favorable for germ cell differentiation.
The ovary is the female homologue of the testis and as such should 
be expected to have similar structures and functions. As spermatogonia 
are the germ cell line in the testis, oogonia are the germ cells of the ovary. 
Whereas the spermatogonia are constantly renewed in the testis, oogonia 
cease replication during fetal development. Oogonia give rise to primary 
oocytes which enter meiosis I during fetal life and proceed to the diplotene 
stage of prophase at which point their maturation is arrested, that is the cell 
enters a resting stage. This event occurs before, or shortly after birth and 
lasts until division is resumed shortly before ovulation. It should be noted 
that the term "resting" refers only to the meiotic inactivity, since arrested 
oocytes continue to synthesize RNA (Zamboni, 1971). It is during 
transcription and subsequent translation that unique proteins may form as a 
result of crossing-over and nondisjunction.
The majority of primary oocytes remain dormant in the ovary until 
the animal reaches puberty at which time an oocyte may resume meiosis. 
Meiosis I is not completed until just prior to ovulation. The resultant 
daughter cells are not equal in terms of cytoplasmic distribution. One 
daughter cell, the secondary oocyte, receives the vast majority of the 
cytoplasm, the other, called the first polar body, receives only a scant
4amount of cytoplasm. Following ovulation the secondary oocyte proceeds 
to metaphase II, at which point further maturation ceases. The second 
meiotic division is completed only if the secondary oocyte is penetrated by 
a spermatozoan. (For a review of oogenesis see Moore, 1988).
It should be reiterated that, unlike the spermatozoa, at no time 
during its ovarian life is the oocyte considered a haploid cell. The 
necessity of a blood-follicle barrier (Shalgi et al., 1973) or a blood-oocyte 
barrier would seem to be in question based upon the above description. 
However, during the growth phase of oogenesis the oocytes synthesize the 
majority of the components that they bring to the event of fertilization. 
Proteins that are known to be synthesized in the growing oocyte include 
tubulin (Schultz et al. 1979), lactate dehydrogenase (Brinster, 1965; 
Mangia et al., 1976), actin and intermediate filament proteins (Kaplan et 
al., 1982), ribosomal proteins (LaMarca and Wassarman, 1979), and the 
proteins of the zona pellucida (Bleil and Wassarman, 1980a; Shimizu et 
al., 1983). It has been documented that the amount of protein synthesized 
by the oocyte when it enters its growth phase is about 38-fold that of a 
resting oocyte (Schultz et al., 1979). If the DNA of the oocyte has 
changed, due to crossing-over, then proteins may be produced that will be 
recognized as foreign by the host (maternal) system. As with the testis, 
interaction of these proteins with the maternal blood may result in the 
production of antibodies that could lead to autoimmune phenomena.
The zona pellucida (ZP) is an amorphous glycoprotein coat which is 
formed during the development of the oocyte, surrounds the oocyte and 
later the blastocyst, and remains intact until implantation (Dunbar, 1983a). 
It first appears at the primary unilaminar follicle stage and is considered to
5be fully formed by the primary multilaminar follicle stage. Because the 
molecules of the ZP are produced and secreted during the early stages of 
oocyte growth and development, they provide excellent markers for this 
dynamic process (Oakberg and Tyrell, 1975; Wolgemuth et al., 1984; 
Philpott et al., 1987).
The zona pellucida is first seen at the light microscopic level at the 
time when the cells surrounding the primary oocyte change from a rather 
flat, squamous cell type to a single layer of cuboidal cells (Died, 1989). 
The ZP does not form as a complete and continuous extracellular 
membrane around the entire circumference of the oocyte but rather as 
discontinuous portions which fuse only secondarily to constitute a complete 
encasement (Died, 1989). The ZP is first recognized as amorphous 
material lying between the pocket-shaped protrusions of microvilli of the 
oocyte membrane and follicular cells. Initially it is found only very 
sparsely distributed in the peri vitelline space. The primary appearance of 
ZP material coincides with an increased number of microvilli of the oocyte 
and cell protrusions of granulosa cells. The microvilli extend into the 
substance of the ZP and tend to be more numerous than the protrusions of 
the adjacent follicle cells. Whereas the plasma membrane of the resting 
oocyte shows only a few short microvilli, they become progressively more 
numerous and uniformly distributed over the surface of the oocyte 
concomitant with the formation of the ZP. Morphologically the maturation 
of ZP begins when amorphous granules appear between the oocyte and 
hypertrophied follicular cells. Greve and Wassarman (1985) identified 
these glycoprotein granules as zona protein one (ZP1) which has cross- 
linking properties with individual filaments within the ZP of the mouse.
6The ZP consists of randomly arranged, fibrillogranular materials that give 
rise to its amorphous appearance observed in scanning electron 
micrographs (Phillips and Shalgi, 1980) and in transmission electron 
micrographs (Wassarman and Josefowicz, 1978; Died and Czuppon, 
1984). There are fine fibrillogranular connections within the developing 
ZP matrix which seem to serve as filament branch points. Perhaps these 
fine granular particles are involved in the branching of ZP filaments. A 
greater degree of polymerization occurs with ZP growth and the formation 
of a glycoprotein network takes place. Ultimately the density of the mature 
ZP fibrils increases. There is, however, a difference in density in the 
mature ZP between the inside (facing the oocyte) and the outside (facing 
the follicular cells): the fibrils being more densely packed inside than 
outside (Dietl and Czuppon, 1984). Further studies have demonstrated that 
the ZP of some species appear to contain multiple layers (Hope, 1965; 
Wolgemuth et al., 1984).
The origin of the ZP has been the subject of some debate, with some 
authors implicating the granulosa cells as the source (Guraya, 1974) while 
others choose the oocyte as the source (Tesoriero, 1977; Haddad and 
Nagai, 1977; and Bleil and Wassarman, 1980b). Some consider the ZP to 
be the product of both the granulosa cells and the oocyte (Chiquoine, 1960; 
Hertig and Adams, 1967).
Indirect evidence exists that granulosa cells produce the ZP matrix. 
When rabbits are immunized with porcine ZP proteins, the oocytes are 
destroyed at the stage at which they begin to initiate formation of the ZP 
matrix (Skinner et al. 1984). Even though there are no remnants of 
oocytes, there are distinct matrices which stain identical to ZP surrounded
7by "granulosa" cells. These matrices are easily distinguished from the 
collapsed remnants of ZP from atretic follicles which do not contain 
granulosa cells within the center of the collapsed ZP. It therefore appears 
from these studies that at least some ZP proteins are produced in the 
absence of the oocyte in vivo (Dunbar et al., 1989). Additional evidence 
for the synthesis of ZP glycoproteins by granulosa cells is provided by 
immunocytochemical localization of ZP glycoproteins in the follicle of the 
rabbit (Wolgemuth et al., 1984).
On the other hand, the oocyte appears to be the primary producer of 
the ZP. Bousquet et al. (1981) found that a ZP antigen originating from 
the oocyte begins to be produced at the stage of the primary follicle. 
Studies of the molecular details of the genes that code for the mouse ZP 
proteins show that these proteins are synthesized only by the oocyte 
genome (Chamberlin et al., 1989). Further studies (Died, 1989) indicate 
that in mouse zona protein three (ZP3) expression appears to be oocyte 
specific and limited to the growth phase of oogenesis. Fully grown oocytes 
do not appear to make ZP proteins (Bleil and Wasserman, 1980b), and 
oocytes from superovulated animals, although still synthesizing proteins, 
no longer synthesize ZP proteins (Shimizu et al., 1983).
Using an immunohistochemical method, Leveille et al. (1987) 
indicated that the native anti-ZP antibody binding material of hamster ZP is 
synthesized in the oocyte itself and not in the granulosa cells. 
Immunocytochemical localization methods have been used to identify ZP 
antigens in the cytoplasm of hamster oocytes (Leveille et al. 1987) and 
rabbit oocytes (Wolgemuth et al. 1984). These studies indicate that at least 
a portion of the ZP is produced in the oocyte.
8Many investigations attempted to characterize the constituent 
macromolecules of the ZP. These studies led to the conclusion that there 
are marked variations in the morphological, biochemical, 
immunochemical, and physiochemical properties of the constituent 
glycoproteins of the ZP in different mammalian species (Bleil and 
Wassarman, 1980 a-c; Dunbar et al., 1981, 1985; Sacco et al. 1981; Drell 
and Dunbar, 1984; Timmons et al., 1987; Yurewicz et al., 1987; Maresh 
and Dunbar, 1987).
A major morphological variation occurs in the thickness of the ZP 
between different mammalian species (Dunbar, 1983a). The ZP 
surrounding fully grown mouse oocytes is 7/*m thick and contains 3-4 ng 
of protein, made up of three major glycoproteins termed zona protein one 
(ZP1), zona protein two (ZP2) and zona protein three (ZP3) (Bleil and 
Wasserman, 1980a; Shimizu et al., 1983). The three proteins appear to be 
organized in a matrix of branched filaments (Greve and Wasserman, 
1985). Certain chemical and enzymatic treatments, specifically
dithiothreitol and chymotrypsin, reduce the branched matrix to individual 
filaments composed of both ZP2 and ZP3, suggesting that ZP1 is 
responsible for the branching (Greve and Wasserman, 1985). Thus, the 
ZP of a fully grown oocyte appears to be an ordered structure of filaments 
composed of ZP2 and ZP3, either together or separate, and held together 
by ZP1.
Hamster ZP proteins in reduced state are resolved into two 
components of apparent molecular weights of 80 kd and 240 kd by SDS- 
Polyacrylamide Gel Electrophoresis (SDS-PAGE). By a second gel
9electrophoresis in the same direction without SDS, a third band of an 
apparent molecular weight of 150 kd appears (Ahuja and Bolwell, 1983).
Three major families of ZP proteins from human ZP (ZP1, 80-120 
kd: ZP2, 73 kd: ZP3, 59-65 kd) and rabbit (ZP1, 100-118 kd; ZP2, 83-110 
kd; ZP3, 80-92 kd), and four major families from squirrel monkey (ZP1, 
63-78 kd; ZP2, 63-70 kd; ZP3, 47-51 kd; ZP4, 43-47 kd) can be separated 
by two-dimensional SDS-PAGE under reducing conditions. A similar 
result was obtained with rabbit ZP proteins by Dunbar et al. (1981). As 
previously described, ZP1 is responsible for cross-linking the fibrillar ZP2 
and ZP3. Recently, Wassarman (1987a,b) described receptors present in 
ZP3 which are responsible for species specificity of sperm binding. 
Recently a fourth glycoprotein has been isolated from the ZP of oviductal 
eggs from the golden hamster. This glycoprotein, termed zona protein 
zero (ZP0) is produced by the epithelial cells of the oviduct and was found 
to be in the weight range of 200-240 kd (Oikawa, 1989; Sakai et al., 
1988). During in vitro fertilization studies, it was found that antibodies 
raised to ZP0 greatly inhibited sperm binding (Sakai et al., 1988).
The permeability of the ZP was the subject of ongoing study for 
many years. Austin and Lovelock (1958) believed that the ZP of the 
rabbit, rat, and hamster are permeable to substances with a molecular 
weight of 1,200 or less. This meant that the vitellus could be considered 
directly accessible to all the known essential food components including 
vitamins, to the majority of pharmacologically active compounds, and to all 
natural steroid hormones. It would not be accessible to most enzymes, 
antigens, antibodies, or protein hormones (Austin, 1961). It was later
10
demonstrated (Anderson, 1967) that horseradish peroxidase (mol. wt. 
40,000) penetrated through the ZP in the ovarian oocyte of the rabbit.
Simmons and Russell (1966) suggested that the ZP may be 
impermeable to immunoglobulins, thereby protecting the embryo from the 
potentially adverse effects of the maternal immune system. Heyner et al. 
(1969) provided support for this theory, stating that immunoglobulins (mol. 
wt. 150,000 - 900,000) might not be expected to pass through the ZP. 
This statement is based on the observation that the development of eight­
cell mouse eggs to the blastocyst stage is uneffected by the presence of 
cytotoxic antibody plus complement in vitro. However, Sellens and 
Jenkinson (1975) indicated that the ZP of the mouse blastocyst was 
permeable to high molecular weight immunoglobulins based on their 
observation that ZP-enclosed embryos were destroyed when exposed to 
serum fractions containing either IgG or IgM and complement.
The inner layers of the follicular cells, the granulosa cells, maintain 
specialized contacts with the oocyte and assist in protein and nucleic acid 
synthesis via metabolic transfer to the oocyte (Anderson and Albertini, 
1976; Gilula et al., 1978; Heller et al., 1981; Brower and Schultz, 1982). 
This may give a false impression as to the permeability of the ZP.
While a considerable amount of information is now available on the 
structure and function of the mature ZP obtained from large ovarian 
follicles or from ovulated ova with respect to their potential roles in the 
fertilization process, few studies have been carried out to evaluate the 
potential roles of the ZP proteins during follicular development or during 
the onset of sexual maturation (Dunbar et. al., 1989).
11
The ZP-encased oocyte residing in the developing follicle is bathed 
in follicular fluid, a substance very similar in composition to serum and 
previously demonstrated to contain immunoglobulins (Matousek et al., 
1986; Kay et al., 1985; Hussein and Bourne, 1984). The protein content 
of human follicular fluid compares to that of blood serum (Manarang- 
Pangan and Menge, 1971; Shalgi et al., 1973; Perricone et al., 1990). 
Although their results differed in respective ratios, all agreed, along with 
Clark (1900) that follicular fluid appears to be mainly derived from blood 
by transudation and not from granulosa cells. This provides evidence that 
the basement membrane of the follicle presents little if any barrier to the 
diffusion of substances from the theca into the follicle.
Perricone et al. (1990) found that the human follicular fluid 
contained functionally active complement proteins in amounts similar to 
those present in normal human serum. Numerous investigations (Sacco, 
1981; Dunbar, 1983b) involving immunization of females with ZP antisera 
indicated that ZP antibodies can indeed reach and combine with the ZP in 
the follicle. ZP-encased eggs obtained from such immunized females have 
all possessed ZP antibody on the ZP surface, as established by microscopic 
or immunofluorescent procedures (Sacco, 1979; Sacco et al., 1983). This 
indicates that the ZP is accessible to blood-borne proteins.
Shalgi et al. (1973), using Ouchterlony double diffusion tests, 
reported the presence of both IgG and IgA in human follicular fluid. 
Proteins with a molecular weight of 150,000, such as IgG were present in 
lower concentrations than normal serum. Proteins of higher molecular 
weight, such as IgM (900,000 mol. wt.) were undetectable in follicular 
fluid, or detectable in trace amounts only. The oocyte is not in direct
12
contact with the follicular fluid, but rather is separated from it by the ZP 
and the cumulus oophorus. Since follicular fluid was found to contain 
components of the complement fixation pathway, the ZP may be the only 
remaining barrier for protection of the oocyte.
The ability of molecules to pass through the ZP may depend not only 
on molecular weight, but also on molecular configuration, degree of 
aggregation, or the charge characteristics of the molecule in relation to the 
ZP itself. Hastings et al. (1972) stated that the ZP might exclude some 
molecules on the basis of binding with these molecules or possibly by 
charge effects. This was supported by experiments which suggested that in 
the rat and mouse the ZP contained compounds that could give rise to a net 
negative charge within the ZP which would impede the entry of molecules 
also bearing a net negative charge (Sellens and Jenkinson, 1975).
Few studies have been conducted on the antigenic composition of 
mammalian ovaries and eggs, however, with the advent of in vitro 
fertilization many investigators have focused their research on this area. 
Autoantibodies to the ZP have been found in the serum of infertile women 
(Shivers and Dunbar, 1977; Mori et al., 1979; and Buckshee and Mhaskar, 
1984). These findings provide further evidence that the ZP is accessible to 
the serum proteins of the maternal blood circulatory system. This is an 
indication that the ovary and its components can be affected by the 
maternal immune system.
If the interaction between the immune system and the ovary, and 
more specifically the follicle and oocyte, are to be investigated, it becomes 
necessary to provide some background information on aspects of the 
immune system deemed pertinent to this study.
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Immunoglobulins are glycoproteins composed of 82-96% 
polypeptide and 4-18% carbohydrate. The polypeptide component 
possesses almost all of the biological properties associated with antibody 
molecules. Antibodies (immunoglobulins) are bifunctional molecules in 
that they bind specifically with antigens and also initiate a variety of 
secondary phenomena, such as complement fixation and histamine release 
by mast cells, which are independent of their specificity for antigens.
Each immunglobulin contains at least one basic unit, or monomer, 
comprised of four polypeptide chains. One pair of identical polypeptide 
chains contains approximately twice the number of amino acids, i.e. is 
approximately twice the molecular weight, of the other pair of identical 
polypeptide chains. The chains of higher molecular weight are thus 
designated heavy (H) chains and those of lower molecular weight 
designated light (L) chains. Each polypeptide chain contains an amino- 
terminal portion and a carboxy-terminal portion, the former termed the 
variable (V) region and the latter termed the constant (C) region. These 
terms denote the heterogeneity or variability in the amino acid residues 
between the two regions.
The part of the antibody molecule that binds antigen is formed only 
by a small number of amino acids in the V region of H and L chains and 
these amino acids are brought into close relationship by the folding of the 
V region.
There are five classes of immunglobulins, designated IgG, IgA, 
IgM, IgD, and IgE. They are defined by antigenic differences in the 
constant regions of the heavy chains.
14
Enzymatic digestion of an IgG molecule using papain yields two 
antigen-binding fragments (Fab) and one crystallizable fragment (Fc). The 
digestion by papain takes place in an area of the molecule known as the 
hinge region. The hinge region is defined as the area of the H chain in the 
C region between the first and second C region domains. This area is 
more flexible and is more exposed to enzymes and chemicals.
Enzymatic digestion of a molecule of IgG using the enzyme pepsin 
yields one F(ab)'2 molecule and small peptides. The F(ab)'2 molecule is 
composed of two Fab units and the hinge region, with intact inter-H chain 
disulfide bonds. The later are left intact since pepsin cleaves the molecule 
on the carboxy-terminal side of these bonds (for a review of 
immunoglobulins see Goodman, 1987).
In adult humans IgG constitutes approximately 75% of the total 
serum immunoglobulin. The IgG class is made up of four subclasses 
designated IgGl, IgG2, IgG3, and IgG4. Immunoglobulin G is the only 
class of immunoglobulin that is known to cross the placental barrier and 
this phenomena is believed to be a receptor mediated event (Goodman, 
1987; Steward, 1974). Immunoglobulin G Fc receptors have been isolated 
and it is believed that these receptors play a role in the transport of IgG 
(Van de Winkel and Anderson, 1991). Rodewald and Kraehenbuhl (1984) 
described a receptor-mediated endocytosis in which large amounts of intact 
IgG were transported across the intestinal epithelium.
It is interesting to note that IgG does not appreciably cross the 
choriocapillaris of the choroid to accumulate in Bruch's membrane (Pino 
and Thouron, 1983). This suggests that capillaries in general may not 
necessarily be permeable to IgG. There is a several-fold rise in the
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microvascular permeability to IgG in the testis of rats at 27-30 days of age 
(Pollanen and Setchell, 1989). It is interesting that this rise in permeability 
coincides with the beginning synthesis of an interleukin-1-alpha-like factor 
by the Sertoli cells (Syed et al., 1988). Interleukin-1 is known to regulate 
the functions of endothelial cells in other tissues (Bevilacqua et al., 1985).
Two additional proteins that are pertinent to this study are albumin 
and female protein (FP). Serum albumin is a highly flexible molecule 
containing 575 amino-acids combined to give an overall molecular weight 
of 65,000. Albumin is characterized by its extreme solubility in water, its 
negative charge of 19 at pH 7.4, and its lack of a carbohydrate moiety 
(Rothschild et al., 1972). It is known that in addition to its role in 
maintaining the colloid osmotic pressure of plasma and interstitial fluid, 
albumin is an important carrier for various molecules such as fatty acids, 
testosterone, estradiol, and thyroid hormones. These molecular complexes 
(ligands) are then presented to the surfaces of the target cells (Corvol and 
Bardin, 1973; Hutter et al., 1984; Ockner et al., 1983).
Estimates of the lymph/plasma albumin ratio revealed that the 
amount of albumin passing from the plasma into interstitial fluid varies 
significantly from organ to organ (Everett and Simmons, 1958; Pino and 
Thouron, 1983; Sharpe, 1979; Williams and Greener, 1984; Williams et 
al., 1981; Yokota, 1983). Considering the different types of endothelium 
found in these various organs, no firm correlation can be established 
between the endothelial structure and the rate of albumin transport. Other 
properties of the endothelial cell may account for the difference in the rate, 
speed, and kinetics of albumin uptake between various tissue (Ghitescu et 
al., 1986). Albumin transport through endothelial cells via transendothelial
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channels (connective transcytosis) and plasmalemmal vesicles (vectoral 
transcytosis) has been described (Ghitescu, 1986; Simionescu, 1981). Sage 
et al. (1984) described a unique albumin binding glycoprotein synthesized 
by bovine, porcine, and human endothelial cells in culture.
Albumin binding sites have been demonstrated on the surfaces of 
liver and heart cells (Ockner et al., 1983; Hutter et al., 1984) as well as 
for endothelial cells of the capillaries (Ghitescu et al., 1986; Schnitzer et 
al., 1988). The binding of the albumin-ligand complex to membrane 
receptors of tissues triggers endocytosis of the hormone-receptor complex 
either with or without the internalization of the albumin (Szego, 1975; 
Shteri et al., 1982; Ockner et al., 1983). Albumin may also be significant 
in its ability to remove ligands from target cells, and by this mechanism 
may mediate functions of steroid-producing and steroid-responding cells 
(Krishna and Spanel-Borowski, 1989).
Female protein (FP) is an alpha globulin found in the serum of the 
female Syrian (golden) hamster, Mesocricetus auratus (Coe, 1977; Coe et 
al., 1981). Female protein is also found in the Kurdistan hamster, 
Mesocricetus brandti, but is not found in Chinese, Armenian, European, or 
Djzungerian hamsters (Coe et al., 1981). Female protein, produced in the 
liver (Coe and Ross, 1985), is a pentamer approximately 13 nm in 
diameter and has a molecular weight of 150,000. The native molecule 
consists of five 30,000 mol. wt. subunits noncovalently assembled to form 
the 150,000 mol. wt. parent molecule (Coe et al., 1981).
Although FP is detected in conspicuous amounts in normal female 
hamster serum (2mg/ml), it is not detectable by simple gel diffusion in 
normal serum from adult males (Coe et al., 1981). The protein is,
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however, detectable for a transient period in young male hamsters (Coe, 
1977; Coe et al., 1981).
Castration of adult males results in a 50-fold increase in the serum 
levels of FP (Coe and Ross, 1990), while administration of testosterone to 
castrated males results in a concomitant decrease in serum levels of FP 
(Coe, 1977; Coe et al., 1981; Coe and Ross, 1990). This would indicate a 
suppressor function of the testicles via testosterone on serum FP in adult 
male hamsters.
Ovarectomized (castrated) female hamsters show no significant drop 
in serum levels of FP, indicating that intact ovaries are not required for 
maintenance of normal serum FP levels. Concomitantly, female hamsters 
injected with testosterone show a significant decrease in serum FP levels, 
indicating that testosterone has a suppressor effect on serum FP in females 
as well as males, i.e. a primary suppressor effect of an androgen (Coe, 
1977; Coe et al., 1981).
Female protein is remarkably similar to two other serum proteins 
found in other animals, C-reactive protein (CRP) and serum amyloid 
protein component (SAP). In fact, FP appears to represent the CRP-SAP 
homologue in Syrian hamsters (Coe et al., 1981). In contrast to FP, CRP 
and SAP are normally present in low serum concentrations and are not 
known to be under sex-hormone control (Coe, 1977). Amino-terminal 
sequence data shows a clear homology between FP and SAP in which 19 of 
23 identifiable residues (83%) were identical. Since CRP and SAP have 
been shown to be homologous (Osmand et al., 1977; Levo et. al., 1977; 
Coe and Ross, 1983) and FP and SAP exhibit 83% homology, the three
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proteins appear to have evolved from the same ancestral gene (Coe et al., 
1981).
Human CRP is the classic acute-phase reactant, which can increase 
almost 1000-fold in serum levels after nonspecific inflammatory stimuli 
(Coe et al., 1981). Numerous biological functions have been shown for 
CRP including activation of complement (Siegel et al., 1974; Kaplan and 
Valanakis, 1974), interaction with T lymphocytes (Croft et al., 1976) and 
platelets (Fiedel and Gewurz, 1976), and enhancement of phagocytosis 
(Kindmark, 1971; Pepys et al., 1978). In contrast, SAP is found in normal 
human and mouse serum, but only in mice does it increase as a typical 
acute-phase reactant after inflammatory stimuli (Pepys et al., 1979).
Once bound to C3, CRP activates the classical complement pathway 
via C3 conversion independent of the presence of specific antibody or 
immunoglobulin (Kaplan and Volanakis, 1974; Pepys et al., 1978). The 
CRP analog in the rabbit, CxRP, was shown to stimulate leukocyte 
migration (Wood, 1951), facilitate phagocytosis (Hokama et al., 1962; 
Kindmark, 1971, 1972), signal enhanced immune response (Wood, 1953), 
and induce lymphocyte-blast formation (Hornung and Friechi, 1971).
Hamster FP, the homologue of CRP and SAP, exhibits some acute- 
phase reactivity. In male hamsters there is a moderate increase in serum 
FP after nonspecific inflammatory stimuli (Coe, 1977; Coe et al., 1981). 
However in female hamsters FP serum levels show a dramatic decrease in 
serum levels during an acute-phase response (Coe and Ross, 1983). 
Hamster FP also activates the classical complement pathway at the level of 
Cl (Coe and Ross, 1985). Immunoglobulin G and female protein are both 
implicated as initiators of the complement fixation pathway.
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Complement is a complex biological system made up of nine protein 
components, designated C1-C9. The first of these components, when 
activated by immune complexes, activates the next component which in 
turn activates the next component in the sequence and so on thus producing 
a cascade effect. The end result of complement fixation is lysis of cell 
membranes leading ultimately to cell death. In addition to its role in cell 
lysis, the complement system also produces proteins which promote 
chemotaxis, i.e. the attraction of polymorphonuclear phagocytes, as well as 
proteins which enhance opsonization.
Briefly, the cascade system is described by Steward (1974). The 
initial step in the activation of the complement sequence by antigen- 
antibody complexes is the binding of Cl to active sites on the Fc region of 
the antibody which has been produced as a result of immune complex 
formation. The Cl recognition unit consists of three subunit types: Clq, 
C lr and Cls, and the reaction with the altered antibody occurs through the 
Clq component, which can bind up to five IgG molecules. This binding 
results in C lr activating Cls. The active form of Cls is an enzyme the 
substrates of which are components C4 and C2. It first catalyzes the 
binding of C4 to the cell and then the binding of C2 to the bound C4. This 
complex (C42) is termed C3 convertase which has C3 as its substrate. At 
this stage two events occur as a result of C3 convertase activity on C3. 
Fragments of C3 called C3a are released and these have anaphylotoxin 
activity, for histamine release, and also are chemotactic for 
polymorphonuclear phagocytes. The major fragment of C3, called C3b, is 
transferred to the target cell membrane, and is recognized by the C3 
binding sites of macrophages leading to immune adherence and subsequent
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phagocytosis. C3b also modifies the C42 enzyme to produce the C423 
enzyme. This acts on C5 which then interacts with C6 and C7 resulting in 
the binding of C567 to the membrane. Also at this stage, further fragments 
with chemotactic and anaphylatoxin activity are produced. As previously 
described, it is known that the complement fixation pathway need not be 
activated by an antigen-antibody complex, but rather may be activated by 
proteins such as CRP, CxRP, SAP, and FP. Finally C8 and C9 become 
attached to the membrane and a lesion is produced. (For an in depth 
review of the complement fixation pathway see Cooper, 1987).
Since the oocyte develops in a manner similar to the spermatocyte, 
and the spermatocyte has been shown to produce surface proteins that are 
antigenic to the maternal immune system, one might assume that the oocyte 
also produces proteins specific to its cell coat. These proteins would label 
the oocyte as a foreign cell, thus a barrier between these cells and the 
maternal immune system is essential. This study proposes that the ZP 
provides the morphological basis of this blood-oocyte barrier. Further 
speculation is made that the oocyte plays a role in its own protection by 
production of complement inhibitors.
MATERIALS AND METHODS
Female golden hamsters (Mesocricetus auratus) were kept on a 
14:10 light dark cycle at 22°C. Only hamsters that had three consecutive 4 
day estrous cycles were used in these studies. Ovulation occurs late on 
day four of the estrous cycle. Day one of the estrous cycle is characterized 
by a conspicuous vaginal discharge. Animals were checked for discharge 
between 0700 and 0900 hours. All animals used in this study were in the 
weight range of 108-230 grams. Animals were anesthetized by 
intraperitoneal (i.p.) injection of phenobarbitol (Nembutal) at lOmg/lOOg 
body weight.
Indirect Immunolabelling Technique 
Hamster ovaries were harvested every four hours throughout the 
estrous cycle beginning at 0200 hours on day one. At the appropriate time, 
animals were injected i.p. with Nembutal (lOmg/lOOg body weight). Upon 
deep anesthesia, the thoracic and abdominal cavities were opened by a 
single incision. An 18 gauge pediatric i.v. cannula was passed down the 
descending aorta to the level of the diaphragm. The right atrium was 
incised to allow for drainage of blood and perfusate from the animal.
Infusion was carried out via a Harvard infusion pump equipped with 
a 50ml disposable syringe. Perfusion via an infusion apparatus was chosen
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over injection by hand because the former allows for control of 
temperature and intraarterial pressure, is documentable, and is 
reproducible whereas manual injection does not provide this regulation 
(Christofferson and Nilsson, 1988). Approximately 50ml of 0.1M 
phosphate (P04) buffer (pH 7.4) was perfused at the rate of 15.3 ml/minute
to allow for flushing of the blood from the vessels. This was immediately 
followed by approximately 150ml of 1% paraformaldehyde in 0.1M P04
buffer (pH 7.4) to obtain optimal preservation of antigenic tissue sites. 
Ovaries were immediately removed, sectioned into four pieces, and further 
processed using a modification of the technique used by Beckstead (1985). 
This technique employed the use of a glycol methacrylate embedding 
medium, which provides for better morphology than can be obtained using 
paraffin. The technique, carried out at 4°C, is as follows: 1) fix for a 
minimum of 6 hours in 4% paraformaldehyde in 0.1M P04; 2) wash for 
one hour in 0.1M P04 buffer with 2% sucrose and 50mM NH4C1, repeat 
twice; 3) wash for one hour in 0.1 M P04 buffer with 50mM NH4C1, repeat 
once; 4) place in JB4 Plus (glycol methacrylate) infiltration medium for a 
minimum of eight hours; 5) embed with JB4 Plus embedding medium 
(Polysciences, Inc.) in number 0 gelatin capsules. A ratio of 1:10 catalyst 
(organic peroxide) to infiltration medium was found to yield blocks of a 
desirable hardness for sectioning. Upon complete polymerization the 
tissue was sectioned at approximately 3/rni on a Sorval Porter-Blum MT2- 
B ultramicrotome using glass knives. The sections were placed on a drop 
of water on glass microscope slides which were then allowed to air dry 
overnight.
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Immunohistochemical procedures were performed in the following 
order and, unless otherwise specified all incubations were carried out in a 
dark, moist chamber at room temperature. Each successive step was 
followed with a rinse of phosphate buffered saline (PBS): 1) etch plastic 
with 10% H20 2 for 15 minutes to expose tissue; 2) apply 0.25% porcine
trypsin in Saline A (Gibco, Santa Clara, CA), pH 7.6 for 10 min at 37°C 
to unmask cross-linked binding sites (Huang, 1976); 3) apply carrier
solution for 30 minutes to bind any nonspecific binding sites; 4) apply 
primary antibody diluted at 1:400 in carrier solution. Primary antibodies 
used were goat anti-hamster IgG or goat anti-mouse IgA (Cappel); 5) 
apply carrier solution for 30 minutes; 6) apply secondary antibody for 1 
hour. Secondary antibodies used were rabbit anti-goat IgG peroxidase- 
conjugated Fab2 fragments diluted at 1:20 in carrier solution, or rabbit 
anti-goat IgG conjugated with fluorescein isothyocyanate (FITC) diluted at 
1:32 in carrier solution; 7) coverslip FITC treated slides with mounting 
medium and seal the edges with nail polish.
Peroxidase conjugated tissue was rinsed with PBS and the peroxidase 
reaction was developed as follows: 1) incubate with 0.01% (0.5mg/ml) 
3,3'-diaminobenzidine (DAB) in 0.1M phosphate buffer for 10 min at 
37°C; 2) incubate with 0.01% DAB in 0.1M phosphate buffer with 0.1% 
H20 2 for 5 min at 37°C; 3) counterstain with Harris' hematoxylin for 6
min, blue in tap water for 2 min, dehydrate in ascending grades of ethanol 
and coverslip using Permount.
The carrier solution was prepared by mixing 1ml of normal serum 
(serum from the same species in which the secondary antibody was 
produced), one gram of bovine serum albumin, 1.5ml of 20% Triton
24
X-100, and 97.5ml of PBS according to A Practical Guide to 
Immunohistochemistry, published by Pel-Freez Clinical Systems. The 
bovine serum albumin aids in binding to nonspecific binding sites and the 
Triton X-100 is used to disrupt cellular membranes.
Mounting medium used for coverslipping fluorescent labelled tissue 
was a mixture of 2.42g tris-base/100 ml distilled water at pH 8.5, 12ml 
Tris at pH 8.5, 4.76ml dimethylsulfoxide (DMSO), 6ml methanol, and 
2.4g of 20.30 polyvinyl alcohol (PVA). Just before use, p- 
phenylenediamine (PPD) was added at lmg/ml to prevent photobleaching 
(Soo Siang Lim-Spiker, personal communication). After coverslipping, the 
edges were sealed with nail polish. A minimum of two hours should pass 
before viewing. It is also important to store slides prepared for 
fluorescence microscopy in a cool, dark container, to prevent premature 
decay of fluorescence.
Controls for the immunohistochemical staining procedure were 
conducted using an antibody substitution technique in which PBS was 
substituted for antibody. Three controls were carried out such that one 
slide was incubated with primary antibody only, one was incubated with 
secondary antibody only, and one was incubated having no exposure to 
antibody.
A series of immunolabelling experiments was also carried out on 
selected tissue using rabbit anti-hamster IgG, rabbit anti-hamster female 
protein, and rabbit anti-hamster albumin as the primary antibody diluted 
1:400 in carrier solution. Tetramethylrhodamine isothiocyanate (TRITC)- 
conjugated goat anti-rabbit IgG diluted 1:40 in PBS or peroxidase-
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conjugated goat anti-rabbit IgG diluted 1:20 in carrier solution was 
employed as the secondary antibody.
An alternate technique for immunohistochemical labelling employing 
microwave irradiation was adapted for use on tissues. This technique has 
been used in the past with some success and greatly reduces the time 
required for immunohistochemical staining (Chiu and Chan, 1987, Leong 
and Milios, 1986, 1990). Microwave irradiation was carried out in a 
Litton Minutemaster, 700 watt microwave oven equipped with a Nordic 
Ware Micro-Go-Round Plus carousel, with roasting tray and cover. Slides 
were placed on a Plexiglass sheet in the roasting tray and distilled water 
was poured into the tray to completely cover the bottom. This allowed for 
even heating of the tissue while providing a moist, covered environment.
Immunohistochemical procedures were performed in the following 
order, with each successive step followed by a PBS rinse: 1) apply 10% 
H20 2 and microwave on setting one for 1 minute 10 seconds, let stand for
3 minutes 50 seconds; 2) apply 0.25% porcine trypsin in saline A and 
microwave on setting one for 1 minute 10 seconds, let stand for 3 minutes 
50 seconds; 3) apply carrier solution and microwave on setting three for 1 
minute 10 seconds; 4) apply primary antibody diluted to 1:400 in carrier 
solution, microwave on setting two for 1 minute 10 seconds; 5) apply 
secondary antibody diluted to 1:20 in carrier solution, microwave on 
setting two for 1 minute 10 seconds, let stand for 3 minutes 50 seconds.
Fluorescent labelled tissues were then coverslipped with mounting 
media as previously described, and peroxidase treated slides were 
developed at 37°C in a water bath, counterstained, and coverslipped with 
permount as previously described.
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The microwave immunohistochemical staining procedure provided 
results similar to the original room temperature technique requiring one 
third of the time, however the labelling did not appear to be consistent 
from one section to another nor was the tissue evenly labelled.
The peroxidase treated tissue was examined and photographed on a 
Olympus BH-TU microscope equipped with an 80a (daylight) filter. FITC 
and TRITC treated tissues were examined for fluorescence and 
photographed on a Nikon Microphot FX Episcopic Fluorescent Microscope 
equipped with a Nikon B-1E filter cube for viewing FITC and a Nikon G- 
1B filter cube for viewing TRITC. The B-1E filter has the following 
illumination properties: excitation filter = 470-490 nm, barrier filter = 
520-560 nm, dichroic mirror = 510 nm. The G-1B filter has the following 
properties: excitation filter = 546 nm, barrier filter = 590 nm, dichroic 
mirror = 580 nm.
To rule out the possibility of this phenomenon being a staining 
artifact of the ovary, ovulated oocytes were stained using the same 
peroxidase techniques previously described. Oviductal oocytes and flushed 
oocytes were studied and in each case these oocytes were found to have 
what appeared to be an intact ZP. Oviductal oocytes were localized by 
sectioning through the oviduct harvested from an animal on day one of the 
estrous cycle. The oviduct had been fixed and embedded in a manner 
identical to the ovaries, as previously described.
Ovulated oocytes were obtained by flushing the oviducts of a 
superovulated hamster. Superovulation was accomplished according to the 
method of Kan et al. (1990). Briefly, 25 international units (IU) of 
pregnant mare serum gonadotropin were injected i.p. at 0800 hours on day
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one of the estrous cycle. Forty eight hours later the animal was injected 
i.p. with 25 IU of human chorionic gonadotropin. Seventeen hours later 
the animal was euthanized by overdose of Phenobarbitol (Nembutal) and 
the oviducts were removed and flushed with PBS. The cumulus masses 
were collected and fixed in 4% paraformaldehyde in 0.1M P04 buffer for
1.5 hours at 4°C.
The tissue was then placed in JB4 Plus infiltration medium at 4°C 
for four hours, and then placed in number 0 gelatin capsules filled with 
JB4 Plus infiltration medium plus catalyst. The capsules were then 
centrifuged (Britton et al. 1991) for three minutes to force the tissue to the 
bottom of the gelatin capsules. The embedding medium was then allowed 
to polymerize overnight.
Thick sections (2/im) were cut on a Sorval Porter-Blum MT2-B 
ultramicrotome using a glass knife and placed on drops of water on glass 
microscope slides which were subsequently dried on a hot plate. Sections 
were then stained with toluidine blue and examined via standard light 
microscopy. Serial sections were examined until oocytes were visualized, 
at which time sections were cut, floated on water on glass slides and 
allowed to air dry overnight. These slides were then 
immunohistochemically stained following the standard staining technique 
previously described. Goat anti-hamster IgG diluted to 1:400 was used as 
the primary antibody and peroxidase-conjugated rabbit anti-goat IgG 
diluted at 1:20 was used as the secondary antibody.
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Electron Microscopy
Ovaries were fixed in vivo by means of infusion via a Harvard 
infusion pump, all infusion being at the rate of 15.3 ml/minute via an 18 
gauge cannula placed in the descending aorta or by cardiac puncture. 
Following incision of the right atrium, 50ml of 0.15M cacodylate buffer, 
pH 7.2, was infused to flush blood from the vessels. Immediately 
following the flushing, 150ml of cacodylate buffered fixative was infused. 
This fixative was a modification of that used by Doerr-Schott and Lichte 
(1986) such that the final concentrations of the components were 0.5% 
paraformaldehyde, 0.75% glutaraldehyde, and 0.06M cacodylate buffer. 
Upon completion of the infusion the ovaries were removed, sectioned into 
four pieces, and placed in fixative for 24 hours at 4°C.
The tissue was removed from the fixative, dehydrated in 
dimethylformamide (DMF), and prepared for embedding in lowicryl K4M 
(Electron Microscopy Sciences) using the following schedule (Altman, 
1984):
50% DMF..................  20 minutes
75% DMF.................  20 minutes
90% DMF.................  20 minutes
2:1 DMF:lowicryl........... 60 minutes
1:1 DMF:lowicryl........... 60 minutes
100% lowicryl................ 24 hours at 4°C
Following the 24 hour infiltration, fresh lowicryl, mixed according to the 
manufacturers specifications, was used for tissue embedding. 
Polymerization of the lowicryl was carried out in a foil-lined Styrofoam 
chamber equipped with a black light (two 18" tubes, 25 watts, General
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Electric) which emitted a wavelength of 360nm. The tissue was placed in 
number 0 gelatin capsules filled with lowicryl and suspended via thin wire 
at a lamp to tissue distance of 10 cm, and subjected to UV light for one 
hour at 4°C.
The tissue blocks were thick sectioned on a Sorval Porter-Blum 
MT2-B ultramicrotome using glass knives. These sections were placed on 
glass slides and stained with toluidine blue. Individual follicles were 
localized under the microscope and the blocks were trimmed to the area of 
a follicle for thin sections. Thin sections (gold to silver) were cut using a 
diamond knife and were transferred to 400 mesh nickel grids.
The grids were immersed in drops of 0.01M PBS with 5% 
ovalbumin for 10 minutes. The grids were then transferred without rinsing 
to drops of rabbit anti-hamster albumin diluted 1:400 with a solution of 
50mM Tris HC1 and 150mM NaCl at pH 7.4 where they were allowed to 
incubate overnight in a dark moist chamber at 4°C. The grids were then 
rinsed three times by placing them in drops of 0.01M PBS for ten minutes. 
Following blotting on lint-free paper the grids were transferred into drops 
of 15nm colloidal gold conjugated to protein A (Janssen) for 30 minutes. 
The colloidal gold was diluted at 1:20 with 1% ovalbumin in 0.02M PBS, 
pH 7.4. The grids were then rinsed three times in drops of 0.02M PBS at 
pH 7.4 for five minutes followed by a final rinse in distilled water for ten 
minutes. The grids were then counterstained by immersion in 1% uranyl 
acetate in 50% ethyl alcohol for 5.5 minutes, rinsing in distilled water and 
immersion in 0.018% lead citrate for 5.5 minutes and a final rinse in 
distilled water. Control tissue was treated with antibody substitution as 
described earlier.
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Grids were viewed and photographed on a JEOL JEM 100S 
transmission electron microscope.
Injection of Labelled Immunoglobulin
Twenty mg samples of chromatographically purified Hamster IgG 
(Cappel) were reconstituted with 2ml of 0.1M Na2HP04 (pH 8.5) and the 
pH was rapidly adjusted to 9.5 with 0.05M NaC03. Three tenths of a
milligram of FITC was added and the pH again was rapidly adjusted to 9.5 
with 0.05M NaC03. This mixture was allowed to react for one hour in the
dark at room temperature. The solution was then separated by gel 
filtration through an 8ml column of Sephadex G-25 which had been swelled 
in physiological saline. Eight 1ml fractions were collected and analyzed in 
a Beckman DU-50 Spectrophotometer. Fractions were pooled such that a 
solution with a final concentration of 5mg/ml was obtained. 
Spectrophotometric analysis estimated an average FITC to IgG ratio of 3:1.
Injection of 1ml of FITC-conjugated hamster IgG solution (5mg/ml) 
was carried out via either the abdominal aorta or the femoral vein. One 
animal was injected at 1000 hours for each of the four days of the estrous 
cycle. The injection mass was allowed to circulate for one hour, at which 
time the ovaries were removed, sectioned into two pieces, and placed in 
4% paraformaldehyde in 0.1M phosphate buffer for four hours. Control 
animals were injected i.v. with 1ml of FITC/physiological saline at the 
same FITC concentration (0.9/zM) as the IgG/FITC solution. This 
injection was allowed to circulate for one hour before harvesting the 
ovaries. One animal from day three of the estrous cycle was injected with 
IgG/FITC and the circulation time was reduced to 30 minutes.
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The tissue was removed from fixative and dehydrated using standard 
ethanol dehydration which was completed in two changes of 100% Hemo 
De (Fisher) for 30 minutes each. The tissue was then passed through a 
50/50 mixture of Hemo De/Paraplast for 30 minutes and then through two 
changes of 100% Paraplast for 30 minutes each before final embedding in 
100% Paraplast.
Paraplast sections were cut at 6/xm, floated on a water bath of 
distilled water and gelatin, and mounted on glass slides. The sections were 
then deparaffinized using two changes of xylene for three minutes each and 
then rinsed with 100% ETOH. The slides were immediately coverslipped 
for fluorescence microscopy, as previously described, sealed with nail 
polish, and placed in the dark at 4°C for at least two hours before viewing 
on the Nikon Microphot FX Episcopic Fluorescent Microscope.
RESULTS
Folliclular development spans more than one estrous cycle and it is 
possible to find virtually any stage of follicular development at any time 
throughout the estrous cycle. In reviewing the ovary sections used in this 
study, follicles of virtually all stages of development, from primary 
unilaminar to antral follicles, were seen at every time period sampled. An 
exception was the occurrence of mature graffian follicles, which were 
visualized mainly in the later time periods (1800 and 2200 hours) on day 
four of the estrous cycle.
Indirect Staining Technique
Treatment of ovary sections with goat anti-hamster IgG (GAH-IgG) 
as a primary antibody followed with peroxidase or FITC-conjugated rabbit 
anti-goat IgG (RAG-IgG) as a secondary antibody resulted in labelling of 
the ZP and remnants of the liquor folliculi. Zonae pellucidae exhibit 
labelling in primary unilaminar follicles and continue throughout 
successive stages of development. The ZP of atretic follicles also label. 
The liquor folliculi did not label in many antral follicles, and in others 
labelling appears to be directed toward one side of the antrum.
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Day one, lOOOh
Follicles from this stage of the cycle exhibit intense labelling of the 
ZP when treated with GAH-IgG followed by FITC-conjugated RAG-IgG 
(Figs. 1 and 2). Control tissue (treated with FITC-conjugated RAG-IgG 
alone) did not exhibit labelling as seen in an ovary harvested at lOOOh of 
day two (Fig. 4).
Day one, 1400h
Large follicles found in ovaries in this stage treated with GAH-IgG 
followed by FITC-conjugated RAG-IgG exhibit intense labelling of the ZP 
with a less intense labelling in the space between the granulosa cells (Fig. 
3). High power magnification of ovary sections reveal a precise
localization of the peroxidase reaction product over the ZP when treated 
with GAH-IgG followed by peroxidase-conjugated RAG-IgG (Figs. 5 and 
7). Similar examination of control tissue (treated with peroxidase-
conjugated RAG-IgG alone) exhibited a faint labelling over the area of the 
ZP (Figs. 6 and 8).
Day two, 0200h
Follicles at this stage of the estrous cycle exhibit labelling over the 
ZP when treated with GAH-IgG followed by peroxidase-conjugated RAG- 
IgG. This can be seen in primary unilaminar follicles as well as in 
multilaminar primary follicles (Fig. 9). Control tissue, consisting of 
sections through the same follicles exhibits only faint labelling when 
treated with peroxidase-conjugated RAG-IgG (Fig. 10).
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Day two, lOOOh
Labelling of the initial stages of ZP formation is seen in a primary 
unilaminar follicle in an ovary harvested at this stage of the estrous cycle 
when treated with GAH-IgG and peroxidase-conjugated RAG-IgG (Fig. 
11). Multilaminar follicles in ovaries from this sample time exhibit 
labelling of the ZP when treated with GAH-IgG followed by either 
peroxidase or FITC-conjugated RAG-IgG (Figs. 13 and 14). Control 
tissue from this sample period did not exhibit labelling when treated with 
FITC-conjugated RAG-IgG alone (Fig. 4).
Day two, 1400h
Ovaries harvested at this stage of the estrous cycle reveal labelling of 
the ZP in unilaminar primary follicles (Fig. 12) and multilaminar primary 
follicles (Fig. 15) treated with GAH-IgG followed by peroxidase- 
conjugated RAG-IgG. Control tissue treated with peroxidase-conjugated 
RAG-IgG show faint labelling (Fig. 16). Tissue from this time period 
treated with goat anti-mouse IgA (GAM-IgA) followed with peroxidase- 
conjugated RAG-IgG show faint labelling of the ZP in follicles ranging 
from unilaminar primary to multilaminar primary (Figs. 17 and 18).
Day three, lOOOh
Zona pellucida in multilaminar follicles in ovaries harvested at this 
stage of the estrous cycle exhibit intense labelling when treated with GAH- 
IgG followed with peroxidase-conjugated RAG-IgG (Figs. 19 and 20). 
Similar results were seen in follicles harvested at day three, 1400 hours 
(Figs. 21 and 22).
35
Day four, 1400h
Ovaries harvested at this stage of the estrous cycle contain 
multilaminar follicles with ZP which exhibit labelling when treated with 
GAH-IgG followed by FITC-conjugated RAG-IgG (Figs. 23 and 24).
Day four, 2200h
Figure 25 demonstrates labelling of a multilaminar follicle in an 
ovary treated with GAM-IgA followed with peroxidase-conjugated RAG- 
IgG. Similarly, the ZP of another multilaminar follicle labels intensely 
when treated with GAH-IgG and peroxidase-conjugated RAG-IgG (Fig. 
26).
Immunohistochemical staining procedures conducted with antibodies 
to hamster IgG, FP, and albumin which were raised in rabbit instead of 
goat, yielded results similar to the above. Ovary sections treated with 
rabbit anti-hamster FP followed by peroxidase-conjugated goat anti-rabbit 
IgG exhibit labelling of ZP (Fig. 27) and liquor folliculi. Treatment of 
tissue with rabbit anti-hamster albumin followed by peroxidase-conjugated 
goat anti-rabbit IgG reveals intense labelling of the ZP (Fig. 28) and liquor 
folliculi.
ZP of oviductal oocytes and oocytes flushed from the oviduct exhibit 
labelling when treated with GAH-IgG followed by peroxidase-conjugated 
GAR-IgG.
Electron Microscopy
Using the protein A gold technique to label the ZP was successful 
with respect to albumin only. Tissue that was treated with rabbit anti­
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hamster IgG as a primary antibody followed by treatment with Protein A 
gold conjugate with 15nm gold particles (PAG-15) did not yield positive 
results in any ovarian tissue type. The same holds true for tissue in which 
the primary antibody used was rabbit anti-hamster FP. However, when 
rabbit anti-hamster albumin is used as the primary antibody followed by 
treatment with PAG-15 there is a remarkably specific localization of the 
gold particles over the ZP (Fig. 29). Control tissue treated with PAG-15 
only exhibited no labelling in the ovary (Fig. 30).
Fluorescein Conjugated Immunoglobulin Injection
To reiterate, fluorescein conjugated hamster IgG was injected i.v. 
into hamsters from each day of the estrous cycle. The injected IgG was 
allowed to circulate for specified periods of time, after which the tissue 
was collected and paraffin embedded as previously described. Subsequent 
tissue sections were viewed and photographed on a fluorescence 
microscope.
Day one, lOOOh
Fluorescence studies of ovaries from this stage of the estrous cycle 
reveal that within one hour of injection, the IgG progressed to the level of 
the ZP (Figs. 31 and 32). Fluorescence is also seen in the liquor folliculi 
and in patches between granulosa cells (Figs. 33) presumably denoting 
initial formation of liquor folliculi. Antral follicles at this time period 
exhibit evidence of atresia (Fig. 34). Remnants of ZP seen at this stage of 
the estrous cycle do not exhibit fluorescence (Fig. 34) as is the case in
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other stages of the cycle (Fig. 38). However, fluorescence is seen in ZP 
remnants which still enclose remnants of oocytes or macophages (Fig. 37).
Day two, lOOOh
Examination of ovarian tissue from this stage of the estrous cycle 
reveal comparable results to those seen on day one. After one hour of 
circulation the IgG progressed to the level of the ZP in small bilaminar 
follicles (Fig. 35) as well as in multilaminar follicles. Patches of
fluorescence are seen between granulosa cells of some multilaminar 
follicles (Figs. 36 and 37) presumably marking the initial formation of the 
liquor folliculi.
Follicles which exhibit labelling of the liquor folliculi at this time 
period also exhibit signs of atresia. Remnants of ZP of follicles from past 
cycles exhibit relatively little labelling (Fig. 38).
Day three, lOOOh
Thirty minutes after injection of fluorescein labelled IgG at this stage 
of the estrous cycle the IgG advanced to the level of the ZP, however there 
appeared to be more fluorescence toward the outside of the ZP (Figs. 39 
and 40). This suggests that thirty minutes may be near the lower limit of 
time required for circulating immunoglobulin to reach the ZP.
Fluorescein labelled IgG injected at this stage of the estrous cycle, 
when allowed to circulate for 1 hour exhibits localization in the ZP as well 
as in the liquor folliculi of developing antral follicles (Fig. 41) and larger 
antral follicles (Fig. 42).
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Day four, lOOOh
Ovaries harvested from animals injected at this stage of the estrous 
cycle demonstrate localization of fluorescein labelled IgG in the ZP (Fig. 
43) and in the liquor folliculi of antral follicles.
Control tissue injected with fluorescein in physiological saline does 
not exhibit fluorescence outside of the blood vessels (Fig. 44).
DISCUSSION
The purpose of this study was to determine if the ZP functions as a 
barrier, limiting access of humoral immune agents to the oocyte. This is 
important in that the oocyte is capable of synthesizing "non-self" proteins 
and may be recognized as foreign by the immune system.
Since the oocyte develops in a manner similar to the spermatocyte, 
and the spermatocyte has been shown to produce proteins on its cell 
surface that are antigenic to the host immune system, one might assume 
that the oocyte also produces antigenic proteins specific to its cell coat. 
Such proteins would identify the oocyte as a foreign cell, therefore these 
cells must be protected against exposure to destructive elements of the 
immune system.
Immunohistochemical labelling techniques were used to determine 
the presence of IgG, FP, and albumin in the hamster ovary. In attempting 
immunohistochemical staining certain problems arise which should be 
considered before choosing a fixative, fixation method and antibody 
conjugate.
In choosing a fixative it is important to remember that fixation 
confers rigidity on tissue mainly by cross-linking proteins. The better the 
cross-linking the better the morphological preservation. It would thus 
seem that a fixative that causes a high degree of cross-linking would be 
preferable for histological preparations. Extensive cross-linking, however,
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impairs antigens both by direct chemical effects and by structural distortion 
(Sternberger, 1986), thus a high degree of cross-linking is not preferable in 
tissue to be used for immunological studies.
A fixative that preserves immunoreactivity with one type of antibody 
may destroy the other epitopes of the same antigen. If one applies region- 
specific immunocytochemistry it becomes evident that different epitopes 
are distinct chemical individuals that react differently with different 
fixatives (Larsson, 1988). In other words, a fixative may preserve 
reactivity of one epitope in a certain antigen, but may completely destroy 
reactivity of other epitopes. Most fixatives bind covalently with amino 
groups and leave carboxy groups and tyrosine and histidine unaffected. In 
short, immunocytochemical detection of antigens in fixed tissue depends 
only on those groups that are not destroyed by the fixative (Sternberger, 
1986). Fixation may also induce conformational changes in the antigens, 
thus total impairment of immunoreactivity may be extensive even though 
the fixative may directly affect only related chemical groups.
Fixation in itself may serve to extract or displace certain antigens. 
Many fixatives penetrate tissues quite slowly. If immersion fixation is to 
be used tissue blocks should be as small as possible otherwise the buffer 
used to dissolve the fixative may reach the tissue first and extract or 
displace the antigen before it is fixed (Larsson, 1988). Whenever possible 
fixation should be by perfusion rather than immersion.
In immunocytochemistry, use of poorly fixed tissue often yields 
spurious results. This is due to nonspecific binding and a high background 
generally attributed to Fc receptors or to "endogenous peroxidases." Red
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blood cells and granulocytes possess a true endogenous peroxidase which 
becomes stained when exposed to diaminobenzidine and hydrogen peroxide 
(Sternberger, 1986). Poorly fixed areas in tissue as well as necrotic areas 
exhibit a tendency toward nonspecific staining even in the absence of 
primary antibody, and this is also referred to as "endogenous peroxidase" 
activity. This activity can be minimized by perfusion of the animal with 
physiological solutions followed by perfusion with fixative. The main 
purpose of the perfusion is not, however, elimination of red blood cells but 
assurance of better fixation than can be afforded by tissue immersion. 
Endogenous peroxidase activity can further be eliminated using various 
techniques such as treatment with methanolic hydrogen peroxide 
(Sternberger, 1986). A logical alternative for avoiding problems with 
endogenous peroxidases is to use staining procedures which do not employ 
diaminobenzidine or hydrogen peroxide, such as immunogold or 
immunofluorescence.
When using immunofluorescence one should consider using the 
mounting media described for coverslipping slides rather than using 
permount since permount has a tendency to fluoresce at various 
wavelengths. Also, this mounting media is preferable to a glycerin 
mounting procedure because the mounting media becomes a gel and 
provides better support and protection for the tissue, especially when 
viewed under high power objectives (100X) which may put pressure on the 
coverslip and inadvertently damage the tissue.
Advances in antibody production and purification now make it 
possible to produce large quantities of highly specific antibodies. This has
42
opened the door to the use of less mild fixatives and many optimal fixatives 
for tissue preservation have found application in immunocytochemistry.
Glutaraldehyde, by virtue of its cross-linking qualities, hardens 
tissues so much that it prevents its own penetration. Mixtures of 
formaldehyde and glutaraldehyde however, do not encounter this difficulty. 
Glutaraldehyde fixation may be followed by osmium tetroxide for further 
membrane stabilization, however if used in postembedding staining 
electron microscopy, the osmium must be removed by oxidation with 
hydrogen peroxide, periodic acid, or permanganate with oxalic acid.
Another consideration before attempting immunocytochemical 
staining is the location of the antigen. Antigens localized in extracellular 
spaces, as well as low molecular weight antigens are more prone to 
extraction or displacement than large molecular weight antigens (Larsson, 
1988).
The tissue generated in this study performed well for light 
microscopic immunolabelling techniques, the only inconsistency being in 
the labelling of the liquor folliculi. The variation in labelling of the liquor 
folliculi of antral follicles may be related to the process of embedding the 
tissue. Since the liquor folliculi is a fluid, it, along with the other fluids of 
the tissue, is replaced by the embedding medium during the process of 
dehydration and infiltration. Thus it would be expected that much of the 
contents of these fluids would be extracted during tissue preparation.
Goat anti-mouse IgA was used as the primary antibody on randomly 
selected tissue to determine the presence of IgA in the ZP. The results 
indicate faint labelling which is due to cross-reactivity between mouse IgA 
and hamster IgA. Cross reactivity between hamster and other species,
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including rodents, is expected to be minimal (John Coe, personal 
communication).
The faint labelling seen in controls treated with rabbit anti-goat IgG 
is attributable to cross-reactivity. This is expected since anti-goat IgG may 
cross-react with the hamster IgG of the ZP.
Labelling problems were encountered when the study shifted to 
electron microscopy. A factor of utmost importance in all 
immunocytochemistry is the binding of secondary antibody to the primary 
antibody. Protein A gold exhibits very weak binding when reacted with 
goat IgG (Amersham technical bulletin) thus poor results, if any, would be 
expected when using GAH-IgG as a primary antibody, as was used in the 
light microscopic study. Protein A gold exhibits strong binding when 
reacted with rabbit IgG (Amersham technical bulletin) thus an anti-hamster 
antibody raised in rabbit should give desirable results as a primary 
antibody followed by treatment with protein A gold.
When using anti-hamster IgG, anti-hamster FP, and anti-hamster 
albumin raised in rabbit followed with PAG-15, positive labelling was seen 
only on albumin treated sections. This would indicate that the anti-hamster 
IgG and anti-hamster FP did not bind to the sections. Since this tissue 
differs from that used in the light microscopic study in two ways, fixative 
used and embedding media, the explanation for the lack of labelling of FP 
and IgG may lie in these two areas.
As previously described, a particular fixative may provide for 
excellent staining of one antigen while completely destroying other 
antigens. A paraformaldehyde/glutaraldehyde mixture was used for 
fixation of tissues to be examined by electron microscopy. In this case
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glutaraldehyde could be implicated as the undesirable fixative since binding 
of the primary antibody to paraformaldehyde fixed tissues did not appear to 
be a problem in the light microscopic study. The use of gluteraldehyde, 
however, was necessary to obtain morphology suitable for electron 
microscopic examination.
The other variable that was changed between the light and electron 
microscopic studies was the use of lowicryl K4M and its accompanying 
preparation for embedding in place of JB4 + . Preparation for embedding 
in JB4+ involved tissue immersion in JB4+ infiltration medium as a 
dehydration procedure whereas lowicryl embedding required tissue 
dehydration prior to immersion in the lowicryl. Dimethylformamide was 
used as the dehydration medium as previously discussed.
In preliminary experiments for light microscopy, DMF was used as 
a dehydrating agent prior to embedding in JB4 + . No morphological 
advantage was seen in tissue prepared in this manner, so the DMF was 
dropped from the protocol. Immunolabelling of the ZP was observed in 
these DMF dehydrated tissues, this would seem to indicate that DMF 
dehydration is compatible with the antigens in question and quite probably 
is not responsible for the failure to label tissues for electron microscopy.
Lowicryl is generally accepted as the polymer of choice when 
working with immunochemistry at the electron microscopic level. One of 
the advantages of lowicryl being that it can be used at low temperatures 
which protects tissues and presumably antigen binding sites. However, 
some antigens that have been detected using immunogold reagents on 
ultrathin frozen sections were undetectable when embedded in lowicryl 
K4M (Kerjaschki et al., 1986). No concrete explanation has been given
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for this phenomena but one possible explanation is that the ultraviolet light 
used for polymerization of the lowicryl may have adverse effects on some 
antigens.
The results of both the light and electron microscopic studies 
indicate that intra-ovarian albumin is localized in the ZP and liquor folliculi 
of hamster ovarian follicles. Albumin has a negative charge, thus it is not 
surprising to find it bound to the ZP since, according to Sellens and 
Jenkinson (1975), the ZP might be expected to bind negatively charged 
molecules. Albumin is also described as a carrier molecule which is 
responsible for mediating functions of steroid-producing and steroid- 
responding cells (Krishna and Spanel-Borowski, 1989). Albumin is also 
implicated in initiating endocytosis of a ligand with or without 
internalization of the albumin itself, as well as being responsible for 
removing ligands from target cells. The possibility then exists for albumin 
to carry substances to the oocyte and at the same time remove proteins 
from the oocyte.
The localization of anti-hamster IgG in the ZP and not in the oocyte 
suggests that the ZP is impermeable to hamster IgG. It is not known if IgG 
is bound to the ZP or if it is merely trapped within the fibrillogranular 
matrix of the ZP. Since IgG is an initiator of the complement fixation 
pathway it would seem imperative to the survival of the oocyte that it not 
be allowed to reach the oocyte where it could literally mark the oocyte as a 
target for cell lysis and phagocytosis.
Anti-hamster FP also localized in the area of the ZP but not within 
the oocyte. This suggests that the ZP of the hamster is impermeable to FP. 
The nature of binding of the FP to the ZP is not known and the possibility
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that FP is trapped in the ZP rather than bound to it must be considered. To 
reiterate, FP is the hamster homologue to serum amyloid protein and/or C- 
reactive protein from other mammals and has been implicated in the 
initiation of the complement fixation pathway and in enhanced 
phagocytosis. Again, a barrier to prevent this protein from reaching the 
oocyte is imperative.
The liquor folliculi is a transudate of blood serum, and as such 
contains many of the same proteins. This means that serum proteins must 
traverse the endothelial wall of the thecal capillaries and pass either 
through or between granulosa cells to reach the ZP and to eventually form 
liquor folliculi in the antral cavity of the follicle.
The injection studies conducted with fluorescein conjugated hamster 
IgG demonstrate that circulating IgG reaches the level of the ZP in less 
than 30 minutes. These also reveal that the immunoglobulin is located 
between granulosa cells, which is in agreement with findings of the indirect 
immunolabelling study. Large patches of fluorescence located between the 
granulosa cells are believed to be the initial stages of development of the 
liquor folliculi and thus depicts the initial formation of the antrum of the 
follicle.
Control animals, injected with FITC in physiologic saline, did not 
exhibit labelling outside of the blood vessels. This indicates that the 
vessels of the theca are not readily permeable to FITC that has been 
conjugated to physiological saline, but are permeable to FITC-conjugated 
IgG. This suggests that a mechanism exists for allowing passage of certain 
molecules while impeding the passage of others. In the case of IgG this 
process may be receptor mediated as previously described.
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Immunoglobulin G is the only class of immunoglobulin that is known to 
cross the placental barrier and this phenomena is believed to be a receptor 
mediated event (Goodman, 1987; Steward, 1974). Immunoglobulin G Fc 
receptors have been isolated and it is believed that these receptors play a 
role in the transport of IgG (Van de Winkel and Anderson, 1991).
Similar studies using fluorescein conjugated serum globulins were 
conducted in the rat by Mancini et al. (1963). They describe patches of 
fluorescence in the oocyte itself. They concluded that the ZP was at least 
partially permeable to serum globulins. The findings of the current study 
do not support their results. No fluorescence, beyond that seen in control 
animals, was seen in the oocytes. Thus the suggestion that the ZP is 
impermeable to serum IgG is supported.
At this point a brief summary of events seems appropriate. The ZP 
and liquor folliculi both label for the presence of IgG, FP, and albumin. 
These proteins are derived from serum and become localized in the ZP and 
antrum.
Since both IgG and FP are known to initiate the complement fixation 
pathway, and all the necessary complement components have been found in 
the liquor folliculi, it seems that a system exists which could cause cell 
death on a large scale. This system would also allow for subsequent 
phagocytosis of the tissue. This allows for the rather rapid and complete 
follicular atresia that is seen in hamsters.
The function of an oocyte is to mature to the stage of ovulation, 
become fertilized, and develop into a viable embryo. If the follicular 
oocyte is surrounded by proteins, the primary function of which is 
complement fixation, then a mechanism must exist which impedes the
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initiation of the complement cascade. Not all follicles mature to ovulation. 
Some become atretic and their cells, including the oocyte, are 
phagocytized. This study raises the possibility that atresia is due to an 
inability on the part of the oocyte to block the complement cascade in the 
follicle. This is evidenced by the fact that remnants of zona pellucida 
atretica seen in the injection study did not exhibit the fluorescence afforded 
by the FITC-conjugated hamster IgG unless remnants of the oocyte or 
phagoctyes were seen inside the borders of the ZP. However ZP remnants 
seen in the indirect labelling study did exhibit labelling. This suggests that 
IgG is not circulated to zona pellucida atretica that do not contain antigenic 
substances.
It has been suggested by Chamberlin et al. (1989) that some proteins 
of the ZP are only coded for by the oocyte genome. The possibility exists 
that one or more of these proteins may function to block the initiation of 
the complement fixation pathway. In order to do this, these proteins would 
themselves have to localize in the ZP. This suggests a possible role for 
albumin in the ZP, since, as previously described, albumin may be 
responsible for extraction of a ligand from the target cell. The albumin 
may be responsible for either the extraction of complement blocking 
proteins from the oocyte or sequestering these proteins in the ZP, or 
perhaps both.
This study suggests that all ovarian follicles are viewed equally by 
the immune system and that only follicles containing oocytes capable of 
producing a complement blocking protein will mature to ovulation. 
Oocytes of atretic follicles perhaps lack the ability to synthesize the 
proteins required to block the complement pathway. This may be brought
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about by chromosomal abnormalities that may have occurred during the 
long arrested prophase of meiosis I.
In summary, the ZP of the hamster has been found to impede the 
entry of IgG, FP,and albumin into the oocyte, thereby providing a barrier 
between the oocyte and the maternal immune system. In addition, the ZP 
holds proteins associated with the complement fixation pathway. Under 
the appropriate conditions the complement system is blocked and the 
oocyte can proceed to ovulation. The suggestion is made that the oocyte is 
responsible for its own survival by producing proteins that block the 
complement cascade. Oocytes which are not capable of providing for their 
own protection become atretic and are phagocytized.
APPENDICES
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Appendix A Plates And Figures 
PLATE I
Figure 1. Fluorescence micrograph of an ovary harvested at 1000 hours 
on day one of the estrous cycle. Treated with GAH-IgG and 
FITC-conjugated rabbit anti-goat IgG as a secondary antibody. 
X 180.
Figure 2. Fluorescence micrograph of a hamster ovary harvested at 
1400 hours on day one of the estrous cycle. Treated with goat 
anti-hamster IgG as a primary antibody and FITC-conjugated 
rabbit anti-goat IgG as a secondary antibody. Note the 
fluorescence between the granulosa cells in the large follicle 
(right). X 460.
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Figure 3.
Figure 4.
PLATE II
Fluorescence micrograph of an ovary harvested at 1400 hours 
on day one of the estrous cycle. Treated with goat anti­
hamster IgG as a primary antibody followed by FITC- 
conjugated rabbit anti-goat IgG as a secondary antibody. Note 
the slight labelling between the granulosa cells as well as the 
labelling of remnants of zona pellucida atretica (upper left). X 
900.
Fluorescence micrograph of an ovary harvested at 1000 hours 
on day two of the estrous cycle. Control tissue treated with 
FITC-conjugated rabbit anti-goat IgG only. X 900.
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Figure 5.
Figure 6.
PLATE III
Light micrograph of an ovarian follicle in an hamster ovary 
harvested at 1400 hours on day one of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 4600.
Light micrograph of an ovarian follicle in an hamster ovary 
harvested at 1400 hours on day one of the estrous cycle. 
Treated with peroxidase-conjugated rabbit anti-goat IgG only. 
X 4600.
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Figure 7.
Figure 8.
PLATE IV
Light micrograph of a hamster ovary harvested at 1400 hours 
on day one of the estrous cycle. Treated with goat anti­
hamster IgG as a primary antibody followed by peroxidase- 
conjugated rabbit anti-goat IgG as a secondary antibody. X 
4600.
Light micrograph of a hamster ovary harvested at 1400 hours 
on day one of the estrous cycle. Treated with peroxidase- 
conjugated rabbit anti-goat IgG only. X 1800.
v  V#
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Figure 9.
Figure 10.
PLATE V
Light micrograph of three follicles located in an ovary 
harvested at 0200 hours on day two of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. Note the faint labelling in the primary 
unilaminar follicle. X 1800.
Light micrograph of section taken through the same follicles 
seen in Fig. 9. Control tissue treated with peroxidase- 
conjugated rabbit anti-goat IgG only. X 1800.
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Figure 11.
Figure 12.
PLATE VI
Light micrograph of a primary unilaminar follicle seen in an 
ovary harvested at 1000 hours on day two of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 4600.
Light micrograph of a primary unilaminar follicle in an ovary 
harvested at 1400 hours on day two of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 4600.
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Figure 13.
Figure 14.
PLATE VII
Light micrograph of an ovary harvested at 1000 hours on day 
two of the estrous cycle. Treated with Goat anti-hamster IgG 
as a primary antibody followed by peroxidase-conjugated 
rabbit anti-goat IgG as a secondary antibody. X 1800.
Fluorescence micrograph of a section through the same 
follicles seen in Fig. 13. Treated with goat anti-hamster IgG 
as a primary antibody followed by FITC-conjugated rabbit 
anti-goat IgG as a secondary antibody. X 1800.
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Figure 15.
Figure 16.
PLATE VIII
Light micrograph of an ovary harvested at 1400 hours on day 
two of the estrous cycle. Treated with goat anti-hamster IgG 
as a primary antibody followed by peroxidase-conjugated 
rabbit anti-goat IgG as a secondary antibody. X 900.
Light micrograph of sections through the same follicles seen in 
Fig. 15. Control tissue treated with peroxidase-conjugated 
rabbit anti-goat IgG only. X 900.
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PLATE IX
Figure 17. Light micrograph of an ovary harvested at 1400 hours on day 
two of the estrous cycle. Treated with goat anti-mouse IgA as 
a primary antibody followed by peroxidase-conjugated rabbit 
anti-goat IgG as a secondary antibody. X 900.
Figure 18. Light micrograph of two multilaminar follicles in an ovary 
harvested at 1400 hours on day two of the estrous cycle. 
Treated with goat anti-mouse IgA as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 1800.
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PLATE X
Figure 19. Light micrograph of a multilaminar follicle in an ovary 
harvested at 1000 hours on day three of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 1800.
Figure 20. Light micrograph of two multilaminar follicles seen in an 
ovary harvested at 1000 hours on day three of the estrous 
cycle. Treated with goat anti-hamster IgG as a primary 
antibody followed by peroxidase-conjugated rabbit anti-goat 
IgG as a secondary antibody. X 1800.
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Figure 21.
Figure 22.
PLATE XI
Light micrograph of a multilaminar follicle seen in an ovary 
harvested at 1400 hours on day three of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 1800.
Light micrograph of an ovary harvested at 1400 hours on day 
three of the estrous cycle. Treated with Goat anti-hamster IgG 
as a primary antibody followed by peroxidase-conjugated 
rabbit anti-goat IgG as a secondary antibody. Note the 
labelling in the small bilaminar follicle (center) as well as the 
labelling of the remnants of the zona pellucida atretica. X 
1800.
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Figure 23.
Figure 24.
PLATE XII
Fluorescence micrograph of a follicle seen in an ovary 
harvested at 1400 hours on day four of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by FITC-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 1800.
Fluorescence micrograph of follicles seen in an ovary 
harvested at 1400 hours on day four of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by FITC-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 1800.
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Figure 25.
Figure 26.
PLATE XIII
Light micrograph of a follicle seen in an ovary harvested at 
2200 hours on day four of the estrous cycle. Treated with 
goat anti-mouse IgA as a primary antibody followed by 
peroxidase-conjugated rabbit anti-goat IgG as a secondary 
antibody. X 1800.
Light micrograph of a multilaminar follicle seen in an ovary 
harvested at 2200 hours on day four of the estrous cycle. 
Treated with goat anti-hamster IgG as a primary antibody 
followed by peroxidase-conjugated rabbit anti-goat IgG as a 
secondary antibody. X 4600.
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PLATE XIV
Figure 27. Light micrograph of a follicle seen in an ovary harvested at 
1400 hours on day four of the estrous cycle. Treated with 
rabbit anti-FP as a primary antibody followed by peroxidase- 
conjugated goat anti-rabbit IgG as a secondary antibody. X 
1800.
Figure 28. Light micrograph of a follicle seen in an ovary harvested at 
1400 hours on day three of the estrous cycle. Treated with 
rabbit anti-albumin as a primary antibody followed by 
peroxidase-conjugated goat anti-rabbit IgG as a secondary 
antibody. X 1800.
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PLATE XV
Figure 29. Electron micrograph of the ZP of a follicle seen in an ovary 
harvested at 1400 hours on day four of the estrous cycle. 
Treated with rabbit anti-hamster albumin as a primary 
antibody followed by PAG-15. X 17,500.
Figure 30. Electron micrograph of the ZP of a follicle seen in an ovary 
harvested at 1400 hours on day four of the estrous cycle. 
Control tissue treated with PAG-15 only. X 16,100.
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Figure 31.
Figure 32.
PLATE XVI
Fluorescence micrograph of a hamster ovary harvested at 
1000 hours on day one of the estrous cycle. The animal was 
injected i.v. with FITC-conjugated hamster IgG one hour 
before euthanasia. Note spots of fluorescence between 
granulosa cells denoting initial formation of liquor folliculi. X 
460.
Fluorescence micrograph of a multilaminar follicle seen in an 
ovary harvested at 1000 hours on day one of the estrous cycle. 
The animal was injected i.v. with FITC-conjugated hamster 
IgG one hour before euthanasia. Note the thin band of 
fluorescence at the level of the granulosa cell basement 
membrane. X 1800.
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PLATE XVII
Figure 33. Fluorescence micrograph of two follicles seen in a hamster 
ovary harvested at 1000 hours on day one of the estrous cycle. 
The animal was injected i.v. with FITC-conjugated hamster 
IgG one hour before euthanasia. Note the fluorescence 
between granulosa cells in the multilaminar follicle (right) and 
in the antrum of the antral follicle (left). X 900.
Figure 34. Fluorescence micrograph of an ovary harvested at 1000 hours 
on day one of the estrous cycle. The animal was injected i.v. 
with FITC-conjugated hamster IgG one hour before 
euthanasia. Note the fluorescence seen in the antrum of the 
two antral follicles (center and left) as well as the lack of 
fluorescence in the remnants of zona pellucida atretica. X 
460.
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Figure 35.
Figure 36.
PLATE XVIII
Fluorescence micrograph of a bilaminar follicle seen in an 
ovary harvested at 1000 hours on day two of the estrous cycle. 
The animal was injected i.v. with FITC-conjugated hamster 
IgG one hour before euthanasia. X 1800.
Fluorescence micrograph of a multilaminar follicle seen in an 
ovary harvested at 1000 hours on day two of the estrous cycle. 
The animal was injected i.v. with FITC-conjugated hamster 
IgG one hour before euthanasia. Note areas of fluorescence 
between granulosa cells presumably marking initial formation 
of liquor folliculi. X 1800.
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PLATE XIX
Figure 37. Fluorescence micrograph of two multilaminar follicles seen in 
an ovary harvested at 1000 hours on day two of the estrous 
cycle. The animal was injectd i.v. with FITC-conjugated 
hamster IgG one hour before euthanasia. X 900.
Figure 38. Fluorescence micrograph of a hamster ovary harvested at 
1000 hours on day two of the estrous cycle. The animal was 
injected i.v. with FITC-conjugated hamster IgG one hour 
before euthanasia. Note the lack of fluorescence of the 
remnants of zona pellucida atretica (center) as well as in the 
ZP of the atretic follicle (right). Also note spots of 
fluorescence on the oocyte coat in the atretic follicle. X 900.
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Figure 39.
Figure 40.
PLATE XX
Fluorescence micrograph of a multilaminar follicle seen in an 
ovary harvested at 1000 hours on day three of the estrous 
cycle. The animal was injected i.v. with FITC-conjugated 
hamster IgG 30 minutes before euthanasia. X 1800.
Fluorescence micrograph of a multilaminar follicle seen in an 
ovary harvested at 1000 hours of day three of the estrous 
cycle. The animal was injected i.v. with FITC-conjugated 
hamster IgG 30 minutes before euthanasia. X 1800.
V
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PLATE XXI
Figure 41. Fluorescence micrograph of an antral follicle as seen in an 
ovary harvested at 1000 hours on day three of the estrous 
cycle. The animal was injected i.v. with FITC-conjugated 
hamster IgG one hour before euthanasia. X 900.
Figure 42. Fluorescence micrograph of an antral follicle seen in an ovary 
harvested at 1000 hours on day three of the estrous cycle. 
The animal was injected i.v. with FITC-conjugated hamster 
IgG one hour before euthanasia. X 900.

93
PLATE XXII
Figure 43. Fluorescence micrograph of three follicles seen in an ovary 
harvested at 1000 hours on day four of the estrous cycle. The 
animal was injected i.v. with FITC-conjugated hamster IgG 
one hour before euthanasia. X 900.
Figure 44. Fluorescence micrograph of three follicles seen in an ovary 
harvested at 1000 hours on day three of the estrous cycle. 
Control tissue - the animal was injected i.v. with FITC in 
physiologic saline one hour before euthanasia. X 900.
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Appendix B Immunological Agents And Their Suppliers
Sigma Chemical Co. St Louis MO
Anti-Goat IgG (Whole Molecule) FITC Conjugate developed 
in rabbit
Anti-Rabbit IgG (Whole molecule) TRITC Conjugate developed 
in goat
Fluorescein Isothiocyanate
Cappel (Organon-Teknika) Durham NC
IgG fraction Goat Anti-Hamster IgG (Heavy and Light 
Chain Specific)
Goat Anti-Mouse IgA (Alpha Chain Specific)
Peroxidase Conjugated IgG fraction Rabbit Anti-Goat IgG 
(F(ab')2 Fragment Specific
Peroxidase Conjugated IgG fraction Goat Anti-Rabbit IgG 
(F(ab')2 fragment specific 
Chromatographically purified Hamster IgG
Janssen (Amersham) Picataway NJ 
Protein A Gold 15 nm
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The following three antibodies were a generous gift from Dr. John Coe at 
the National Institute of Health, Rocky Mountain Laboratory, Hamilton, 
MT:
Rabbit Anti-Hamster IgG nonspecific 
Rabbit Anti-Hamster Female Protein 
Rabbit Anti-Hamster Albumin
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